Skip to main content
. 2024 Nov 20;24:770. doi: 10.1186/s12884-024-06970-6
neonatal outcomes Non-GDM group
(n = 1570)
GDM group
(n = 436)
OR (95% CI) aOR (95% CI) P-value Adjusted
prematurity < 37 weeks 992(63.2) 268(61.5) 0.93(0.68,1.27) 0.94(0.69,1.29) 0.712
< 34 weeks 166(10.6) 58(13.3) 1.30(0.83,2.04) 1.39(0.87,2.21) 0.164
sex(male) 781(49.7) 206(47.2) 0.90(0.71,1.14) 0.87(0.68,1.11) 0.260
RDS 113(7.2) 38(8.7) 1.23(0.76,1.99) 1.31(0.80,2.14) 0.289
neonatal asphyxia 47(3.0) 20(4.6) 1.56(0.80,3.05) 1.93(0.97,3.87) 0.063
delivery weight discordance > 25% 100(6.4) 30(6.9) 1.09(0.60,1.97) 1.07(0.58,1.98) 0.836
hypoglycemia 57(3.6) 17(3.9) 1.08(0.60,1.94) 1.04(0.58,1.88) 0.887
necrotizing enterocolitis 60(3.8) 16(3.7) 0.96(0.51,1.79) 1.00(0.53,1.87) 0.995
neonatal infection 55(3.5) 16(3.7) 1.05(0.57,1.92) 1.25(0.70,2.31) 0.472
neonatal jaundice 321(20.4) 90(20.6) 1.01(0.73,1.41) 098(0.70,1.38) 0.912
neonatal malformation 20(1.3) 10(2.3) 1.82(0.75,4.44) 1.86(0.75,4.58) 0.178
respiratory system diseases 269(17.1) 84(19.3) 1.15(0.83,1.61) 1.20(0.86,1.69) 0.281
hyperbilirubinemia 55(3.5) 22(5.0) 1.46(0.85,2.54) 1.63(0.94,2.85) 0.084

Generalized estimating equations (GEE)models adjusted for maternal age, pre-pregnancy BMI, early and middle pregnancy BMI gain, history of GDM, family history of type II diabetes, and geographic differences as covariates. *:P < 0.05